Sorafenib Clinical Trials
13 recruitingDrug
Phase 210Phase 32Phase 12
Showing 1–13 of 13 trials
Recruiting
Phase 3
MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Acute Myeloid Leukemia (AML)Maintenance TherapyAllogeneic Hematopoietic Cell Transplantation (HCT)+3 more
The First Affiliated Hospital of Soochow University594 enrolled2 locationsNCT07463651
Recruiting
Phase 1Phase 2
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Hepatocellular CarcinomaRefractory Solid TumorPediatric Solid Tumor+3 more
St. Jude Children's Research Hospital64 enrolled2 locationsNCT05468359
Recruiting
Phase 2
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
Hepatocellular Carcinoma
University of Florida12 enrolled1 locationNCT05669339
Recruiting
Phase 2
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
Hepatocellular Carcinoma
Humanity & Health Medical Group Limited30 enrolled1 locationNCT03899428
Recruiting
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Ze-yang Ding, MD300 enrolled2 locationsNCT05713994
Recruiting
Phase 2
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Locally Advanced Thyroid Gland Carcinoma
West China Hospital75 enrolled1 locationNCT06482086
Recruiting
Phase 2
Combination of Toripalimab and JS004 Therapy for ccRCC
Clear Cell Renal Cell Carcinoma
Fudan University80 enrolled1 locationNCT06690697
Recruiting
Phase 2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
Breast CancerBreast NeoplasmHER2-negative Breast Cancer+2 more
Fudan University620 enrolled1 locationNCT05594095
Recruiting
Phase 2
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
Acute Myeloid LeukemiaAML, Childhood
Children's Hospital of Soochow University500 enrolled13 locationsNCT06221683
Recruiting
Phase 2
Sorafenib Relapase Prophylaxis After HCT With PTBCy Regimen
Chronic Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more
St. Petersburg State Pavlov Medical University88 enrolled1 locationNCT06532084
Recruiting
Phase 1Phase 2
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
Hepatocellular CarcinomaHCC
Assiut University150 enrolled1 locationNCT06527495
Recruiting
Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma Non-resectable
Tongji Hospital300 enrolled4 locationsNCT05717738
Recruiting
Phase 2Phase 3
Treateament of Newly Diagnosed Acute Monocytic Leukemia in Children
Pediatric AMLLeukemia, Monocytic, Acute
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University43 enrolled9 locationsNCT05313958